Please login to the form below
2
Revenue 2017Novartis
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.
myVOXZOGO: Personalized Caregiver Support at their Fingertips
by Complete HealthVizion for Novartis. ... Revolutionizing Medical Engagement for a More Sustainable Future: The Halls of Science and Innovation - by Complete HealthVizion for Novartis.
Psoriasis and Beyond Study: Looking Beyond the Skin
by IPG PR for Novartis. # Almost one-in-three people with psoriasis will develop psoriatic arthritis. ... Psoriasis and Beyond Study: Looking Beyond the Skin - by IPG PR for Novartis.
Face Up To Rosacea
by Havas Life Medicom for Novartis UK. ... Live Life with ITP - by Havas Life Medicom for Novartis UK.
Beneath The Surface: A European Position Paper on the Neurocognitive Impact and Care of PKU
by IPG PR for Novartis. ... Psoriasis and Beyond Study: Looking Beyond the Skin - by IPG PR for Novartis.
MS in the 21st Century: ‘myMS’ Tools to Empower Patients in Shared-Care Decisions
by Havas Life Medicom for Novartis UK. ... Live Life with ITP - by Havas Life Medicom for Novartis UK.
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- Environment: where does the pharmaceutical industry stand?
- bluebird bio reveals plans to launch two gene therapies
- Novartis reports death of two patients treated with Zolgensma
- ONS data reveals significant decrease in COVID-19 antibodies
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- Are we the masters or servants of omnichannel engagement?
- JCVI publishes advice on COVID-19 vaccines ahead of autumn booster campaign
- AstraZeneca and Daiichi Sankyo’s Enhertu shows significant improvement for breast cancer patients
- Gilead Sciences announce positive results for Trodelvy in breast cancer patients
- UK government to launch national mission to tackle dementia
- WHO publishes first position paper on optimising brain health
- Amgen acquires ChemoCentryx in $3.7bn cash deal
- Sanofi halts recruitment for trials assessing MS treatment
- AstraZeneca and Daiichi Sankyo announce results for lung cancer therapy
- JCVI publishes statement on London polio vaccination strategy
- Low-dose LSD looks safe for Alzheimer’s patients, but will it work?
- Michael J Fox Foundation awards Koneksa second research grant
PMHub
EPG Health
REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...
Latest intelligence
- Environment: where does the pharmaceutical industry stand?
- ...
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
